1. Home
  2. ARKO vs PRTA Comparison

ARKO vs PRTA Comparison

Compare ARKO & PRTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ARKO Corp.

ARKO

ARKO Corp.

HOLD

Current Price

$4.65

Market Cap

520.4M

Sector

Energy

ML Signal

HOLD

Logo Prothena Corporation plc

PRTA

Prothena Corporation plc

HOLD

Current Price

$9.54

Market Cap

495.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ARKO
PRTA
Founded
1970
2012
Country
United States
Ireland
Employees
N/A
N/A
Industry
Oil Refining/Marketing
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
520.4M
495.8M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
ARKO
PRTA
Price
$4.65
$9.54
Analyst Decision
Buy
Buy
Analyst Count
3
9
Target Price
$7.50
$18.86
AVG Volume (30 Days)
401.6K
787.9K
Earning Date
11-05-2025
11-06-2025
Dividend Yield
2.59%
N/A
EPS Growth
N/A
N/A
EPS
0.11
N/A
Revenue
$7,887,822,000.00
$11,786,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$819.08
P/E Ratio
$42.57
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.51
$4.32
52 Week High
$7.84
$16.67

Technical Indicators

Market Signals
Indicator
ARKO
PRTA
Relative Strength Index (RSI) 45.08 42.93
Support Level $4.58 $9.23
Resistance Level $5.35 $9.88
Average True Range (ATR) 0.18 0.51
MACD -0.06 -0.07
Stochastic Oscillator 9.80 19.51

Price Performance

Historical Comparison
ARKO
PRTA

About ARKO ARKO Corp.

ARKO Corp owns and operates convenience stores in the United States. Some of its regional store brands include Stop, Admiral, Apple Market, BreadBox, E-Z Mart, fas mart, Li'l Cricket, and Next Door Store. Its retail store offers hot food service, beverages, cigarettes & other tobacco products, candy, salty snacks, grocery, beer, and general merchandise. ARKO operates in four segments: Retail segment, Wholesale segment, fleet fueling segment, and GPM Petroleum segment. The company derives the majority of its revenue from retail and wholesale distribution of fuel.

About PRTA Prothena Corporation plc

Prothena Corp PLC is a clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including ATTR amyloidosis [Coramitug (PRX004)], Alzheimer's disease (PRX123), Neurodegeneration (PRXPRX019), and Others.

Share on Social Networks: